|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/55 | (2006.01) |
| A61K 39/39558 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 35/17 | (2015.01) | ||
| A61K 31/55 | (2013.01) | ||
| A61P 37/02 | (2006.01) | ||
| A61K 35/17 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 14/70578 | (2013.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 37/00 | (2018.01) | ||
| C12N 15/62 | (2006.01) | ||
| C07K 16/2878 | (2013.01) | ||
| C07K2317/622 | (2013.01) | ||
| C07K2319/03 | (2013.01) | ||
| C07K2319/33 | (2013.01) | ||
| A61K 31/4245 | (2013.01) | ||
| A61K 31/5513 | (2013.01) | ||
| C07K 14/7051 | (2013.01) | ||
| A61K2039/5158 | (2013.01) | ||
| A61K2039/5156 | (2013.01) | ||
| A61K 39/001117 | (2018.08) |
| (11) | Number of the document | 3582782 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18712281.7 |
| Date of filing the European patent application | 2018-02-16 | |
| (97) | Date of publication of the European application | 2019-12-25 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/000050 |
| Date | 2018-02-16 |
| (87) | Number | WO 2018/151836 |
| Date | 2018-08-23 |
| (30) | Number | Date | Country code |
| 201762460612 P | 2017-02-17 | US | |
| 201762582270 P | 2017-11-06 | US |
| (72) |
RIDDELL, Stanley, R. , US
GREEN, Damian , US
HILL, Tyler , US
|
| (73) |
Fred Hutchinson Cancer Center ,
1100 Fairview Avenue North, Seattle, WA 98109,
US
|
| (54) | COMBINATION THERAPIES FOR TREATMENT OF BCMA-RELATED CANCERS AND AUTOIMMUNE DISORDERS |
| COMBINATION THERAPIES FOR TREATMENT OF BCMA-RELATED CANCERS AND AUTOIMMUNE DISORDERS |